About Claris Bio
Claris Bio is a late-stage biopharmaceutical company that develops biologic therapies for corneal diseases and other disorders affecting the ocular surface. The company researches and develops recombinant hepatocyte growth factor–based treatments designed to restore corneal structure and function. Its pipeline includes topical ophthalmic biologic candidates for conditions such as neurotrophic keratopathy, limbal stem cell deficiency, and corneal scarring. Claris Bio conducts preclinical and clinical research, translational science, and manufacturing activities.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $118,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $57,000,000 · Series-A
- Milestone
Website domain registered
clarisbio.com
- Milestone
Company founded
Jersey City, United States
Investors & Backers
Funding History
Founders & Leadership
Brian Baum
Chief Commercial Officer
Clarke Atwell
Founder
Henry Rath
Chief Business Officer
Reza Dana
Founder
Stephen Brady
President and CEO
Sunil Chauhan
Founder
Susan Orr
Chief Medical Officer
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com